Olaparib in Patients With HRD Malignant Mesothelioma

Clinical trial NCT04515836 · RECRUITING

Trial details

NCT number: NCT04515836
Sponsor: University of Chicago
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mesothelioma Homologous Recombination Deficiency

Start date: 2021-02-19
Primary completion: 2028-04-15
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.